LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
0.8000
-0.0055 (-0.68%)
Sep 17, 2025, 4:00 PM EDT - Market closed
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $32.97 million as of September 17, 2025. Its market cap has decreased by -61.91% in one year.
Market Cap
32.97M
Enterprise Value
86.43M
1-Year Change
-61.91%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $32.97M, a decrease of -85.52%. That is a compound annual growth rate of -37.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 33.20M | -49.72% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
| Aug 5, 2021 | 227.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 672.40B |
| Johnson & Johnson | 426.78B |
| AbbVie | 380.55B |
| UnitedHealth Group | 314.95B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 230.99B |